SCHEMBL1034732

SCHEMBL1034732

CC(C)Oc1ccc2c(Cl)nc(OC(=O)NCCN)c(O)c2c1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
MTNR1A P48039 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
EGLN1 Q9GZT9 4/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
SYK P43405 1/20 0.34
TOP2A P11388 2/20 0.33
BCHE P06276 2/20 0.33
PDCD1LG2 Q9BQ51 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
LIPE Q05469 1/20 0.33
PLAU P00749 1/20 0.33
ACACB O00763 2/20 0.33
ACHE P22303 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1032619 0.96 THRA (0.39) NPC1RAB9AMTNR1ASMN1; SMN2EGLN1
SCHEMBL1033120 0.91 SMN1; SMN2 (0.47) NPC1RAB9AMTNR1ASMN1; SMN2EGLN1
SCHEMBL1031021 0.89 NPC1 (0.38) NPC1RAB9AMTNR1ASMN1; SMN2EGLN1
SCHEMBL1033428 0.88 NPC1 (0.37) NPC1RAB9AMTNR1ASMN1; SMN2EGLN1
SCHEMBL1030683 0.86 SMN1; SMN2 (0.47) NPC1RAB9AMTNR1ASMN1; SMN2EGLN1
SCHEMBL1033585 0.84 THRA (0.41) NPC1RAB9AMTNR1ASMN1; SMN2EGLN1
SCHEMBL1032319 0.84 THRA (0.38) NPC1RAB9AMTNR1ASMN1; SMN2EGLN1
SCHEMBL522146 0.83 EGLN1 (0.50) EGLN1THRATHRB
SCHEMBL1033757 0.82 SCN9A (0.35) NPC1RAB9AMTNR1AEGLN1THRA
SCHEMBL1033539 0.81 EGLN1 (0.46) EGLN1THRATHRBPDCD1LG2CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644336-B1 NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND THEIR USE IN INCREASING ENDOGENEOUS ERYTHROPOIETIN FIBROGEN INC (US) 2011-01-19 EP claimed